Jaguar Health, Inc. (NASDAQ: JAGX) Overview – December 2021 Forward-Looking Statements This presentation contains forward-looking statements. All statements other than statements of historical facts contained in this presentation, including statements regarding plans by Jaguar Health, Inc. ("Jaguar" or the "Company") and Napo Therapeutics S.p.A. ("Napo Therapeutics", formerly known as "Napo EU") to develop and commercialize crofelemer in Europe (excluding Russia) for HIV-related diarrhea and short bowel syn ...